{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:39:15Z","timestamp":1793039955906,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Immunol"],"DOI":"10.1186\/s12865-024-00679-z","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T02:59:46Z","timestamp":1736823586000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["IL-6 and PD-1 antibody blockade combination therapy regulate inflammation and T lymphocyte apoptosis in murine model of sepsis"],"prefix":"10.1186","volume":"26","author":[{"given":"Song I","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaeuk","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongil","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da Hyun","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duk Ki","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Kyung","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pureum","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Eun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,14]]},"reference":[{"issue":"10219","key":"679_CR1","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","volume":"395","author":"KE Rudd","year":"2020","unstructured":"Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, Colombara DV, Ikuta KS, Kissoon N, Finfer S, et al. Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the Global Burden of Disease Study. Lancet (London, England). 2020;395(10219):200\u201311.","journal-title":"Lancet (London, England)"},{"issue":"13","key":"679_CR2","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1001\/jama.2014.2637","volume":"311","author":"KM Kaukonen","year":"2014","unstructured":"Kaukonen KM, Bailey M, Suzuki S, Pilcher D, Bellomo R. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000\u20132012. JAMA. 2014;311(13):1308\u201316.","journal-title":"JAMA"},{"key":"679_CR3","doi-asserted-by":"publisher","first-page":"d3245","DOI":"10.1136\/bmj.d3245","volume":"342","author":"J Phua","year":"2011","unstructured":"Phua J, Koh Y, Du B, Tang YQ, Divatia JV, Tan CC, Gomersall CD, Faruq MO, Shrestha BR, Gia Binh N, et al. Management of severe sepsis in patients admitted to Asian intensive care units: prospective cohort study. BMJ (Clinical research ed). 2011;342:d3245.","journal-title":"BMJ (Clinical research ed)"},{"issue":"12","key":"679_CR4","doi-asserted-by":"publisher","first-page":"e993","DOI":"10.1097\/CCM.0000000000004041","volume":"47","author":"SY Oh","year":"2019","unstructured":"Oh SY, Cho S, Kim GH, Jang EJ, Choi S, Lee H, Ryu HG. Incidence and Outcomes of Sepsis in Korea: A Nationwide Cohort Study From 2007 to 2016. Crit Care Med. 2019;47(12):e993\u20138.","journal-title":"Crit Care Med"},{"issue":"1","key":"679_CR5","doi-asserted-by":"publisher","first-page":"36","DOI":"10.4161\/viru.25436","volume":"5","author":"WJ Wiersinga","year":"2014","unstructured":"Wiersinga WJ, Leopold SJ, Cranendonk DR, van der Poll T. Host innate immune responses to sepsis. Virulence. 2014;5(1):36\u201344.","journal-title":"Virulence"},{"issue":"6","key":"679_CR6","first-page":"669","volume":"27","author":"H Chaudhry","year":"2013","unstructured":"Chaudhry H, Zhou J, Zhong Y, Ali MM, McGuire F, Nagarkatti PS, Nagarkatti M. Role of cytokines as a double-edged sword in sepsis. In vivo (Athens, Greece). 2013;27(6):669\u201384.","journal-title":"In vivo (Athens, Greece)"},{"issue":"8","key":"679_CR7","doi-asserted-by":"publisher","first-page":"959","DOI":"10.2217\/imt-2016-0020","volume":"8","author":"T Tanaka","year":"2016","unstructured":"Tanaka T, Narazaki M, Kishimoto T. Immunotherapeutic implications of IL-6 blockade for cytokine storm. Immunotherapy. 2016;8(8):959\u201370.","journal-title":"Immunotherapy"},{"issue":"1","key":"679_CR8","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1186\/s12879-019-4618-7","volume":"19","author":"J Song","year":"2019","unstructured":"Song J, Park DW, Moon S, Cho HJ, Park JH, Seok H, Choi WS. Diagnostic and prognostic value of interleukin-6, pentraxin 3, and procalcitonin levels among sepsis and septic shock patients: a prospective controlled study according to the Sepsis-3 definitions. BMC Infect Dis. 2019;19(1):968.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"679_CR9","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/hep.22034","volume":"47","author":"B Gao","year":"2008","unstructured":"Gao B, Jeong WI, Tian Z. Liver: An organ with predominant innate immunity. Hepatology (Baltimore, MD). 2008;47(2):729\u201336.","journal-title":"Hepatology (Baltimore, MD)"},{"issue":"8","key":"679_CR10","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1056\/NEJM199908193410807","volume":"341","author":"M Levi","year":"1999","unstructured":"Levi M, Ten Cate H. Disseminated intravascular coagulation. N Engl J Med. 1999;341(8):586\u201392.","journal-title":"N Engl J Med"},{"issue":"7","key":"679_CR11","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1002\/eji.201040391","volume":"40","author":"A Kimura","year":"2010","unstructured":"Kimura A, Kishimoto T. IL-6: regulator of Treg\/Th17 balance. Eur J Immunol. 2010;40(7):1830\u20135.","journal-title":"Eur J Immunol"},{"issue":"6490","key":"679_CR12","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1126\/science.abb8925","volume":"368","author":"JB Moore","year":"2020","unstructured":"Moore JB, June CH. Cytokine release syndrome in severe COVID-19. Science. 2020;368(6490):473\u20134.","journal-title":"Science"},{"issue":"6","key":"679_CR13","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1097\/CCM.0b013e318211ff56","volume":"39","author":"T Barkhausen","year":"2011","unstructured":"Barkhausen T, Tschernig T, Rosenstiel P, van Griensven M, Vonberg RP, Dorsch M, Mueller-Heine A, Chalaris A, Scheller J, Rose-John S, et al. Selective blockade of interleukin-6 trans-signaling improves survival in a murine polymicrobial sepsis model. Crit Care Med. 2011;39(6):1407\u201313.","journal-title":"Crit Care Med"},{"issue":"11","key":"679_CR14","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.3390\/ijms18112413","volume":"18","author":"NK Patil","year":"2017","unstructured":"Patil NK, Guo Y, Luan L, Sherwood ER. Targeting immune cell checkpoints during sepsis. Int J Mol Sci. 2017;18(11):2413.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"679_CR15","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/nri3552","volume":"13","author":"RS Hotchkiss","year":"2013","unstructured":"Hotchkiss RS, Monneret G, Payen D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol. 2013;13(12):862\u201374.","journal-title":"Nat Rev Immunol"},{"key":"679_CR16","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3389\/fimmu.2020.00487","volume":"11","author":"JM Jubel","year":"2020","unstructured":"Jubel JM, Barbati ZR, Burger C, Wirtz DC, Schildberg FA. The role of PD-1 in acute and chronic infection. Front Immunol. 2020;11:487.","journal-title":"Front Immunol"},{"key":"679_CR17","first-page":"1969474","volume":"2018","author":"Q Zhang","year":"2018","unstructured":"Zhang Q, Qi Z, Bo L, Li CS. Programmed cell death-1\/programmed death-ligand 1 blockade improves survival of animals with sepsis: a systematic review and meta-analysis. Biomed Res Int. 2018;2018:1969474.","journal-title":"Biomed Res Int"},{"issue":"6","key":"679_CR18","doi-asserted-by":"publisher","first-page":"R220","DOI":"10.1186\/cc9354","volume":"14","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, Zhou Y, Lou J, Li J, Bo L, Zhu K, Wan X, Deng X, Cai Z. PD-L1 blockade improves survival in experimental sepsis by inhibiting lymphocyte apoptosis and reversing monocyte dysfunction. Crit Care (London, England). 2010;14(6):R220.","journal-title":"Crit Care (London, England)"},{"issue":"23","key":"679_CR19","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1056\/NEJMra2026131","volume":"383","author":"DC Fajgenbaum","year":"2020","unstructured":"Fajgenbaum DC, June CH. Cytokine Storm. N Engl J Med. 2020;383(23):2255\u201373.","journal-title":"N Engl J Med"},{"issue":"2","key":"679_CR20","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrneph.2017.165","volume":"14","author":"F Venet","year":"2018","unstructured":"Venet F, Monneret G. Advances in the understanding and treatment of sepsis-induced immunosuppression. Nat Rev Nephrol. 2018;14(2):121\u201337.","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"679_CR21","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0891-5520(05)70083-0","volume":"13","author":"T van der Poll","year":"1999","unstructured":"van der Poll T, van Deventer SJ. Cytokines and anticytokines in the pathogenesis of sepsis. Infect Dis Clin North Am. 1999;13(2):413\u201326, ix.","journal-title":"Infect Dis Clin North Am"},{"key":"679_CR22","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.cyto.2016.08.033","volume":"88","author":"L Ma","year":"2016","unstructured":"Ma L, Zhang H, Yin YL, Guo WZ, Ma YQ, Wang YB, Shu C, Dong LQ. Role of interleukin-6 to differentiate sepsis from non-infectious systemic inflammatory response syndrome. Cytokine. 2016;88:126\u201335.","journal-title":"Cytokine"},{"key":"679_CR23","doi-asserted-by":"publisher","first-page":"624279","DOI":"10.3389\/fimmu.2020.624279","volume":"11","author":"Y Nakamori","year":"2020","unstructured":"Nakamori Y, Park EJ, Shimaoka M. Immune deregulation in sepsis and septic shock: reversing immune paralysis by targeting PD-1\/PD-L1 pathway. Front Immunol. 2020;11:624279.","journal-title":"Front Immunol"},{"issue":"4","key":"679_CR24","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.it.2006.02.001","volume":"27","author":"T Okazaki","year":"2006","unstructured":"Okazaki T, Honjo T. The PD-1-PD-L pathway in immunological tolerance. Trends Immunol. 2006;27(4):195\u2013201.","journal-title":"Trends Immunol"},{"key":"679_CR25","doi-asserted-by":"publisher","first-page":"165974","DOI":"10.1155\/2013\/165974","volume":"2013","author":"W Schulte","year":"2013","unstructured":"Schulte W, Bernhagen J, Bucala R. Cytokines in sepsis: potent immunoregulators and potential therapeutic targets\u2013an updated view. Mediators Inflamm. 2013;2013:165974.","journal-title":"Mediators Inflamm"},{"issue":"4","key":"679_CR26","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.immuni.2019.03.026","volume":"50","author":"S Kang","year":"2019","unstructured":"Kang S, Tanaka T, Narazaki M, Kishimoto T. Targeting Interleukin-6 Signaling in Clinic. Immunity. 2019;50(4):1007\u201323.","journal-title":"Immunity"},{"issue":"11","key":"679_CR27","doi-asserted-by":"publisher","first-page":"7814","DOI":"10.1002\/jcp.30394","volume":"236","author":"W Lei","year":"2021","unstructured":"Lei W, Liu D, Sun M, Lu C, Yang W, Wang C, Cheng Y, Zhang M, Shen M, Yang Z, et al. Targeting STAT3: A crucial modulator of sepsis. J Cell Physiol. 2021;236(11):7814\u201331.","journal-title":"J Cell Physiol"},{"issue":"7","key":"679_CR28","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrrheum.2017.83","volume":"13","author":"S Rose-John","year":"2017","unstructured":"Rose-John S, Winthrop K, Calabrese L. The role of IL-6 in host defence against infections: immunobiology and clinical implications. Nat Rev Rheumatol. 2017;13(7):399\u2013409.","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"679_CR29","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/nrd.2018.45","volume":"17","author":"C Garbers","year":"2018","unstructured":"Garbers C, Heink S, Korn T, Rose-John S. Interleukin-6: designing specific therapeutics for a complex cytokine. Nat Rev Drug Discov. 2018;17(6):395\u2013412.","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"679_CR30","doi-asserted-by":"publisher","first-page":"e0232612","DOI":"10.1371\/journal.pone.0232612","volume":"15","author":"J Lokau","year":"2020","unstructured":"Lokau J, Kleinegger F, Garbers Y, Waetzig GH, Gr\u00f6tzinger J, Rose-John S, Haybaeck J, Garbers C. Tocilizumab does not block interleukin-6 (IL-6) signaling in murine cells. PLoS ONE. 2020;15(5):e0232612.","journal-title":"PLoS ONE"},{"issue":"3","key":"679_CR31","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/QCO.0b013e3283528c9b","volume":"25","author":"MA Kovach","year":"2012","unstructured":"Kovach MA, Standiford TJ. The function of neutrophils in sepsis. Curr Opin Infect Dis. 2012;25(3):321\u20137.","journal-title":"Curr Opin Infect Dis"},{"issue":"9","key":"679_CR32","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1111\/jcmm.13112","volume":"21","author":"XF Shen","year":"2017","unstructured":"Shen XF, Cao K, Jiang JP, Guan WX, Du JF. Neutrophil dysregulation during sepsis: an overview and update. J Cell Mol Med. 2017;21(9):1687\u201397.","journal-title":"J Cell Mol Med"},{"key":"679_CR33","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.cca.2021.09.012","volume":"523","author":"S Kumar","year":"2021","unstructured":"Kumar S, Payal N, Srivastava VK, Kaushik S, Saxena J, Jyoti A. Neutrophil extracellular traps and organ dysfunction in sepsis. Clinica Chimica; Acta Int J Clin Chem. 2021;523:152\u201362.","journal-title":"Clinica Chimica; Acta Int J Clin Chem"},{"issue":"2","key":"679_CR34","doi-asserted-by":"publisher","first-page":"e0148142","DOI":"10.1371\/journal.pone.0148142","volume":"11","author":"PG Czaikoski","year":"2016","unstructured":"Czaikoski PG, Mota JM, Nascimento DC, S\u00f4nego F, Castanheira FV, Melo PH, Scortegagna GT, Silva RL, Barroso-Sousa R, Souto FO, et al. Neutrophil extracellular traps induce organ damage during experimental and clinical sepsis. PLoS ONE. 2016;11(2):e0148142.","journal-title":"PLoS ONE"},{"key":"679_CR35","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3389\/fimmu.2016.00155","volume":"7","author":"F S\u00f4nego","year":"2016","unstructured":"S\u00f4nego F, Castanheira FV, Ferreira RG, Kanashiro A, Leite CA, Nascimento DC, Col\u00f3n DF, Borges Vde F, Alves-Filho JC, Cunha FQ. Paradoxical roles of the neutrophil in sepsis: protective and deleterious. Front Immunol. 2016;7:155.","journal-title":"Front Immunol"},{"issue":"3","key":"679_CR36","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1164\/rccm.200306-846OC","volume":"170","author":"HM Razavi","year":"2004","unstructured":"Razavi HM, le Wang F, Weicker S, Rohan M, Law C, McCormack DG, Mehta S. Pulmonary neutrophil infiltration in murine sepsis: role of inducible nitric oxide synthase. Am J Respir Crit Care Med. 2004;170(3):227\u201333.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"679_CR37","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.bj.2020.09.001","volume":"44","author":"SC Yang","year":"2021","unstructured":"Yang SC, Tsai YF, Pan YL, Hwang TL. Understanding the role of neutrophils in acute respiratory distress syndrome. Biomed J. 2021;44(4):439\u201346.","journal-title":"Biomed J"},{"issue":"4","key":"679_CR38","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1159\/000345943","volume":"5","author":"J Rossaint","year":"2013","unstructured":"Rossaint J, Zarbock A. Tissue-specific neutrophil recruitment into the lung, liver, and kidney. J Innate Immun. 2013;5(4):348\u201357.","journal-title":"J Innate Immun"},{"key":"679_CR39","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.3389\/fimmu.2019.01888","volume":"10","author":"B Niu","year":"2019","unstructured":"Niu B, Zhou F, Su Y, Wang L, Xu Y, Yi Z, Wu Y, Du H, Ren G. Different expression characteristics of lag3 and pd-1 in sepsis and their synergistic effect on T cell exhaustion: a new strategy for immune checkpoint blockade. Front Immunol. 2019;10:1888.","journal-title":"Front Immunol"},{"issue":"4","key":"679_CR40","doi-asserted-by":"publisher","first-page":"R183","DOI":"10.1186\/cc10332","volume":"15","author":"GP Otto","year":"2011","unstructured":"Otto GP, Sossdorf M, Claus RA, R\u00f6del J, Menge K, Reinhart K, Bauer M, Riedemann NC. The late phase of sepsis is characterized by an increased microbiological burden and death rate. Crit Care (London, England). 2011;15(4):R183.","journal-title":"Crit Care (London, England)"},{"issue":"7","key":"679_CR41","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1016\/j.ajpath.2018.03.016","volume":"188","author":"SW Mateer","year":"2018","unstructured":"Mateer SW, Mathe A, Bruce J, Liu G, Maltby S, Fricker M, Goggins BJ, Tay HL, Marks E, Burns G, et al. IL-6 Drives neutrophil-mediated pulmonary inflammation associated with bacteremia in murine models of colitis. Am J Pathol. 2018;188(7):1625\u201339.","journal-title":"Am J Pathol"},{"issue":"5","key":"679_CR42","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1097\/CCM.0000000000003685","volume":"47","author":"RS Hotchkiss","year":"2019","unstructured":"Hotchkiss RS, Colston E, Yende S, Angus DC, Moldawer LL, Crouser ED, Martin GS, Coopersmith CM, Brakenridge S, Mayr FB, et al. Immune checkpoint inhibition in sepsis: a phase 1b randomized, placebo-controlled, single ascending dose study of antiprogrammed cell death-ligand 1 antibody (BMS-936559). Crit Care Med. 2019;47(5):632\u201342.","journal-title":"Crit Care Med"},{"issue":"1","key":"679_CR43","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/nprot.2008.214","volume":"4","author":"D Rittirsch","year":"2009","unstructured":"Rittirsch D, Huber-Lang MS, Flierl MA, Ward PA. Immunodesign of experimental sepsis by cecal ligation and puncture. Nat Protoc. 2009;4(1):31\u20136.","journal-title":"Nat Protoc"},{"issue":"1","key":"679_CR44","doi-asserted-by":"publisher","first-page":"503","DOI":"10.4049\/jimmunol.170.1.503","volume":"170","author":"NC Riedemann","year":"2003","unstructured":"Riedemann NC, Neff TA, Guo RF, Bernacki KD, Laudes IJ, Sarma JV, Lambris JD, Ward PA. Protective effects of IL-6 blockade in sepsis are linked to reduced C5a receptor expression. J Immunol. 2003;170(1):503\u20137.","journal-title":"J Immunol"},{"key":"679_CR45","doi-asserted-by":"publisher","first-page":"101317","DOI":"10.1016\/j.ienj.2023.101317","volume":"69","author":"G Kabil","year":"2023","unstructured":"Kabil G, Hatcher D, Frost SA, Shetty A, McNally S. Facilitators and barriers of appropriate and timely initial fluid administration in sepsis: a qualitative study. Int Emerg Nurs. 2023;69:101317.","journal-title":"Int Emerg Nurs"},{"issue":"1","key":"679_CR46","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s13054-018-2157-z","volume":"22","author":"KE Rudd","year":"2018","unstructured":"Rudd KE, Kissoon N, Limmathurotsakul D, Bory S, Mutahunga B, Seymour CW, Angus DC, West TE. The global burden of sepsis: barriers and potential solutions. Crit Care (London, England). 2018;22(1):232.","journal-title":"Crit Care (London, England)"},{"issue":"1","key":"679_CR47","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41420-023-01766-7","volume":"9","author":"M Cao","year":"2023","unstructured":"Cao M, Wang G, Xie J. Immune dysregulation in sepsis: experiences, lessons and perspectives. Cell Death Discov. 2023;9(1):465.","journal-title":"Cell Death Discov"},{"issue":"9","key":"679_CR48","doi-asserted-by":"publisher","first-page":"11553","DOI":"10.1007\/s13277-016-5098-7","volume":"37","author":"N Kumari","year":"2016","unstructured":"Kumari N, Dwarakanath BS, Das A, Bhatt AN. Role of interleukin-6 in cancer progression and therapeutic resistance. Tumour Biol. 2016;37(9):11553\u201372.","journal-title":"Tumour Biol"},{"issue":"1","key":"679_CR49","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/s42003-020-01308-2","volume":"3","author":"R Tanaka","year":"2020","unstructured":"Tanaka R, Ichimura Y, Kubota N, Saito A, Nakamura Y, Ishitsuka Y, Watanabe R, Fujisawa Y, Kanzaki M, Mizuno S, et al. Activation of CD8 T cells accelerates anti-PD-1 antibody-induced psoriasis-like dermatitis through IL-6. Commun Biol. 2020;3(1):571.","journal-title":"Commun Biol"},{"issue":"1","key":"679_CR50","doi-asserted-by":"publisher","first-page":"15316","DOI":"10.1038\/s41598-020-72136-x","volume":"10","author":"S Imbaby","year":"2020","unstructured":"Imbaby S, Matsuda N, Tomita K, Hattori K, Palikhe S, Yokoo H, Hattori Y. Beneficial effect of STAT3 decoy oligodeoxynucleotide transfection on organ injury and mortality in mice with cecal ligation and puncture-induced sepsis. Sci Rep. 2020;10(1):15316.","journal-title":"Sci Rep"},{"issue":"2","key":"679_CR51","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1136\/gutjnl-2016-311585","volume":"67","author":"TA Mace","year":"2018","unstructured":"Mace TA, Shakya R, Pitarresi JR, Swanson B, McQuinn CW, Loftus S, Nordquist E, Cruz-Monserrate Z, Yu L, Young G, et al. IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer. Gut. 2018;67(2):320\u201332.","journal-title":"Gut"},{"key":"679_CR52","doi-asserted-by":"crossref","unstructured":"Zhang W, Liu Y, Yan Z, Yang H, Sun W, Yao Y, Chen Y, Jiang R. IL-6 promotes PD-L1 expression in monocytes and macrophages by decreasing protein tyrosine phosphatase receptor type O expression in human hepatocellular carcinoma. J Immunother Cancer. 2020;8(1).","DOI":"10.1136\/jitc-2019-000285"},{"key":"679_CR53","doi-asserted-by":"publisher","first-page":"5501","DOI":"10.12659\/MSM.907439","volume":"24","author":"J Li","year":"2018","unstructured":"Li J, Xu J, Yan X, Jin K, Li W, Zhang R. Targeting Interleukin-6 (IL-6) sensitizes anti-PD-L1 treatment in a colorectal cancer preclinical model. Med Sci Monit: Int Med J Exper Clin Res. 2018;24:5501\u20138.","journal-title":"Med Sci Monit: Int Med J Exper Clin Res"},{"issue":"Suppl 1","key":"679_CR54","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1097\/01.shk.0000191414.94461.7e","volume":"24","author":"WJ Hubbard","year":"2005","unstructured":"Hubbard WJ, Choudhry M, Schwacha MG, Kerby JD, Rue LW 3rd, Bland KI, Chaudry IH. Cecal ligation and puncture. Shock (Augusta, Ga). 2005;24(Suppl 1):52\u20137.","journal-title":"Shock (Augusta, Ga)"}],"container-title":["BMC Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-024-00679-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12865-024-00679-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-024-00679-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T15:53:01Z","timestamp":1736869981000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcimmunol.biomedcentral.com\/articles\/10.1186\/s12865-024-00679-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,14]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["679"],"URL":"https:\/\/doi.org\/10.1186\/s12865-024-00679-z","relation":{},"ISSN":["1471-2172"],"issn-type":[{"value":"1471-2172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,14]]},"assertion":[{"value":"2 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal procedures were performed in accordance with the guidelines of the Animal Care and Use Committee of the Chonnam National University (CNUH-021-A0016).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3"}}